8-K: Nu-Med Plus Secures $450K in Private Placement

Nu-Med Plus, Inc. has entered into subscription agreements for a private placement, raising $450,000 through the sale of Series A Preferred Stock.

Summary

• Nu-Med Plus, Inc. announced on October 19, 2026, that it entered into Subscription Agreements with two accredited investors.
• These agreements resulted in the purchase of 171,232 shares of Series A Preferred Stock for an aggregate of $450,000, at a price of $2.628 per share.
• The company also issued 50,000 shares of Series A Preferred Stock to an individual consultant for services rendered.
• These securities were sold under exemptions from registration pursuant to Section 4(a)(2) and/or Rule 506 of Regulation D of the Securities Act.
• The investors received piggy-back registration rights for shares issuable upon conversion of their preferred stock.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a neutral to slightly negative development due to the unregistered sale of equity securities and the inherent risks associated with private placements, despite the capital raised.

Positives

• Successfully raised $450,000 in capital through a private placement.
• Secured funding from two accredited investors.
• Issued preferred stock for services, potentially conserving cash.

Negatives

• The sale of equity securities was unregistered, relying on exemptions which carry inherent risks and limitations.
• The issuance of shares to a consultant for services could be seen as a dilutive measure if not managed effectively.
• The conversion of Series A Preferred Stock could lead to significant dilution of common stock.

Risks

• The securities sold have not been registered under the Securities Act and may not be offered or sold in the U.S. without registration or an applicable exemption.
• There may not be any public market for the securities, and investors may not be able to liquidate their investment.
• The conversion of Series A Preferred Stock could result in substantial dilution to existing common stockholders.
• The offering was made on a 'best efforts, no minimum' basis, meaning the company was not guaranteed to raise a specific amount.

Future Outlook

The filing does not contain specific forward-looking statements or guidance regarding future financial performance. The primary focus is on the completion of the private placement and the terms of the agreements.

Management Comments

• The company entered into Subscription Agreements with two accredited investors for the purchase of Series A Preferred Stock.
• The company issued Series A Preferred Stock to an individual consultant for services rendered.
• The company claims an exemption from registration for these issuances pursuant to Section 4(a)(2) and/or Rule 506 of Regulation D of the Securities Act.

Industry Context

StockSavvy.ai notes that private placements are a common method for early-stage or growth-stage companies to raise capital when public markets may be less accessible or favorable. However, they often come with limitations on resale and potential dilution.

Stakeholder Impact

• Shareholders: Potential dilution from the conversion of Series A Preferred Stock into common stock.
• Investors: Acquisition of Series A Preferred Stock with registration rights, but subject to restrictions on resale.
• Consultant: Received equity in exchange for services, potentially reducing immediate cash outflow for the company.

Next Steps

• The company will likely use the proceeds from the private placement for its general corporate purposes.
• Investors will hold Series A Preferred Stock, with potential future conversion into common stock.
• The company may need to file a resale registration statement for the investors' shares within two years, subject to conditions.

Key Dates

Recommendation

The capital raise is a positive step, but the reliance on unregistered securities and potential for significant dilution warrants a cautious 'hold' recommendation. Further analysis of the company's use of funds and future growth prospects is needed for a more definitive recommendation.

Keywords

private placement, Series A Preferred Stock, equity financing, accredited investors, unregistered securities, capital raise, piggy-back registration rights, consultant shares